×
For best experience we recommend to activate Javascript in your browser.
RIPK1 antibody (AA 1-430)
This anti-RIPK1 antibody is a Mouse Monoclonal antibody detecting RIPK1 in WB and ELISA. Suitable for Human.
Quick Overview for RIPK1 antibody (AA 1-430) (ABIN355761)
Target
See all RIPK1 Antibodies
RIPK1
(Receptor (TNFRSF)-Interacting serine-threonine Kinase 1 (RIPK1))
Reactivity
All reactivities for RIPK1 antibodies
Human
Host
All hosts for RIPK1 antibodies
Mouse
Clonality
All clonalities for RIPK1 antibodies
Monoclonal
Conjugate
All conjugates for RIPK1 antibodies
This RIPK1 antibody is un-conjugated
Application
All applications for RIPK1 antibodies
Western Blotting (WB), ELISA
Product Details anti-RIPK1 Antibody
(hide)
Binding Specificity
All epitopes for RIPK1 antibodies
AA 1-430
Specificity
Recognizes Receptor-Interacting Serine/Threonine-Protein Kinase.
Purification
Protein G Column
Immunogen
Recombinant N-terminal region of RIP (aa1-430).
Isotype
IgG2b
Alternatives
(show)
Application Details
(hide)
Application Notes
ELISA (1:8000), WB (1:12000)
Restrictions
For Research Use only
Handling
(hide)
Concentration
Lot specific
Buffer
PBS, pH 7.2
Storage
4 °C/-20 °C
Storage Comment
Long term: Add glycerol (40-50%) -20°C, Short term: +4°C
Target Details for RIPK1
(hide)
Target
RIPK1
(Receptor (TNFRSF)-Interacting serine-threonine Kinase 1 (RIPK1))
Alternative Name
RIPK1 / RIP
Background
Standard Gene Symbol: RIPK1, Gene Family: Protein Kinase, Gene Subfamily: RIP, Synonyms: RIPK1, Cell death protein RIP, Receptor interacting protein, RIP1, RIP, RIP-1, Protein kinase rip, Receptor-interacting protein 1, Rinp
Gene ID
8737
UniProt
Q13546
Pathways
NF-kappaB Signaling , Apoptosis , Caspase Cascade in Apoptosis , TLR Signaling , Activation of Innate immune Response , Inositol Metabolic Process , Positive Regulation of Endopeptidase Activity , Hepatitis C , Protein targeting to Nucleus , Toll-Like Receptors Cascades , Negative Regulation of intrinsic apoptotic Signaling , SARS-CoV-2 Protein Interactome , Ubiquitin Proteasome Pathway
Recently viewed
(hide)
Chat with us , powered by LiveChat